Our results with actinomycin D were in keeping with the published reports that actinomycin D, at low doses, stabilizes p53 in response to ribosomal stress by releasing ribosomal proteins that bind MDM2 [51, 64], but our data indicated that this method was not the most effective in eradicating cancer cells that express wild-type p53. Here, MDM2 is linked to cancer.